Tracer library / [11C]3-MeO-4-AP

[11C]3-MeO-4-AP

Also written as [11C]3-MeO-4-AP
Radionuclide
C-11
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
NeuroinflammationDosimetry and biodistribution studies

What it is

Compound class
4-Aminopyridine (4AP) derivative, PET tracer
Target / mechanism
K+ channel PMID 37034655
Clinical application
Imaging demyelination (e.g., in multiple sclerosis) PMID 37034655
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [11C]3-MeO-4-AP, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 37034655, 38683467. Stage set/updated at stage 39 from PMID 37034655: 'In preclinical studies, [ 11 C]3MeO4AP has shown promise due to its high brain permeability, high metabolic stability, high plasma availability, and high in vivo binding affinity.'.